Choline phosphate-based bioactive hydrogel for sustained release of exosomes from adipose-derived stem cells to enhance diabetic wound healing.
He X., Wang Y., Yang D., Liu J., Kang X., Sun T.
Animal Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, Immune Modulation, published in Colloids Surf B Biointerfaces (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Colloids Surf B Biointerfaces (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41846095
- DOI
- 10.1016/j.colsurfb.2026.115618
Abstract (original English)
Diabetic non-healing wounds remain a formidable clinical challenge, often leading to severe complications and high morbidity. Their impaired healing capacity is largely attributed to insufficient neovascularization, chronic inflammation, reduced collagen deposition, and a high risk of bacterial infection. Adipose-derived mesenchymal stem cell exosomes (AE) have shown promise in wound repair by promoting immunomodulation and neovascularization. However, traditional physical loading methods frequently result in exosome loss or inactivation, limiting their therapeutic efficacy. To overcome these limitations, we develop a Gelatin Methacryloyl-methacrylated choline phosphate bioactive hydrogel via free radical polymerization. This bioactive hydrogel incorporates AE through specific "choline phosphate-phosphatidylcholine" (CP-PC) conjugation, ensuring their stability and sustained release, while antibacterial metal-organic frameworks, activated by blue light and enhancing curcumin bioavailability, are physically blended into the hydrogel matrix. The bioactive hydrogel accelerates wound healing by suppressing bacterial growth and reducing inflammation during the initial phase, enhancing endothelial cell migration and tubule formation in the proliferative phase. In vitro and in vivo evaluations confirm its potent antibacterial, anti-inflammatory, and antioxidant activities, significant
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations